Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Co-administered OPV and OCV
NCT03581734Phase 3Unknown
- Sponsor
- icddr,b
- Start
- Jul 2018
- Primary completion
- Oct 2022
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of cholera vaccine (inactivated, oral), bivalent oral poliovirus vaccine in cholera, poliomyelitis, sponsored by icddr,b. Status: unknown.
02
Drugs
cholera vaccine (inactivated, oral)bivalent oral poliovirus vaccine
03
Conditions
cholerapoliomyelitis
Beyond the preview
Go deeper on NCT03581734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03581734.